Form 4: Editas Medicine EVP, CHIEF MEDICAL OFFICER Baisong Mei Reports Sale of Shares to Cover Tax Obligations

Baisong Mei, EVP, CHIEF MEDICAL OFFICER of Editas Medicine, Inc., sold 518 shares of common stock on September 4, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On September 4, 2024, Baisong Mei, the EVP, CHIEF MEDICAL OFFICER of Editas Medicine, Inc., sold 518 shares of common stock.
• The sale was executed at a weighted average price of $3.4247 per share, with individual trades ranging from $3.4246 to $3.4501.
• The transaction was conducted under a pre-arranged automatic sales plan adopted on June 14, 2022.
• The purpose of the sale was to meet tax withholding obligations resulting from the vesting of restricted stock units on September 2, 2024.
• Following the transaction, Mei directly owns 133,895 shares of Editas Medicine, Inc.
• The reporting person has undertaken to provide full information regarding the number of shares and prices at which the transaction was effected, upon request, to the SEC staff, the Issuer or a security holder of the Issuer.

Sentiment

Score: 7

Explanation: The document reflects a neutral event (sale of shares for tax purposes) and doesn't indicate any significant positive or negative sentiment regarding the company's performance or future prospects.

Industry Context

This is a routine Form 4 filing, indicative of insider transactions related to equity compensation. It's common for executives to sell shares to cover tax obligations when restricted stock units vest.

Stakeholder Impact

• The sale of shares by an executive could have a minor, temporary impact on shareholder sentiment, but is unlikely to have a significant long-term effect.

Key Dates